<img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081&amp;ev=PageView &amp;noscript=1">
  • Menu
  • crown-logo-symbol-1-400x551

Find it Quickly

Get Started

Select the option that best describes what you are looking for

  • Services
  • Models
  • Scientific Information

Search Here For Services

Click Here to Start Over

Search Here For Models

Click Here to Start Over

Search Here For Scientific Information

Click Here to Start Over

In Vitro

Boost oncology drug discovery with XenoBase®, featuring the largest cell line selection and exclusive 3D organoid models. Benefit from OrganoidXplore™ and OmniScreen™ for rapid, in-depth analysis.

Learn More

In Vivo

Enhance drug development with our validated in vivo models, in vitro/ex vivo assays, and in silico modeling. Tailored solutions to optimize your candidates.

Learn More

Tissue

Experience ISO-certified biobanking quality. Access top biospecimens from a global clinical network, annotated by experts for precise research.

Learn More

Biomarkers and Bioanalysis

Leverage our global labs and 150+ scientists for fast, tailored project execution. Benefit from our expertise, cutting-edge tech, and validated workflows for reliable data outcomes.

Learn More

Data Science and Bioinformatics

Harness your data and discover biomarkers with our top bioinformatics expertise. Maximize data value and gain critical insights to accelerate drug discovery and elevate projects.

Learn More

KRAS

Accelerate innovative cancer treatments with our advanced models and precise drug screening for KRAS mutations, efficiently turning insights into clinical breakthroughs.

Learn More

EGFR

Advance translational pharmacology with our diverse pre-clinical models, robust assays, and data science-driven biomarker analysis, multi-omics, and spatial biology.

Learn More

Drug Resistance

Our suite integrates preclinical solutions, bioanalytical read-outs, and multi-omics to uncover drug resistance markers and expedite discovery with our unique four-step strategy.

Learn More

Patient Tissue

Enhance treatments with our human tumor and mouse models, including xenografts and organoids, for accurate cancer biology representation.

Learn More

Bioinformatics

Apply the most appropriate in silico framework to your pharmacology data or historical datasets to elevate your study design and analysis, and to improve your chances of clinical success.

Learn More

Biomarker Analysis

Integrate advanced statistics into your drug development projects to gain significant biological insight into your therapeutic candidate, with our expert team of bioinformaticians.

Learn More

CRISPR/Cas9

Accelerate your discoveries with our reliable CRISPR solutions. Our global CRISPR licenses cover an integrated drug discovery platform for in vitro and in vivo efficacy studies.

Learn More

Genomics

Rely on our experienced genomics services to deliver high quality, interpretable results using highly sensitive PCR-based, real-time PCR, and NGS technologies and advanced data analytics.

Learn More

In Vitro High Content Imaging

Gain more insights into tumor growth and disease progression by leveraging our 2D and 3D fluorescence optical imaging.

Learn More

Mass Spectrometry-based Proteomics

Next-generation ion mobility mass spectrometry (MS)-based proteomics services available globally to help meet your study needs.

Learn More

Ex Vivo Patient Tissue

Gain better insight into the phenotypic response of your therapeutic candidate in organoids and ex vivo patient tissue.

Learn More

Spatial Multi-Omics Analysis

Certified CRO services with NanoString GeoMx Digital Spatial Profiling.

Learn More

Biomarker Discovery

De-risk your drug development with early identification of candidate biomarkers and utilize our biomarker discovery services to optimize clinical trial design.

Learn More

DMPK Services

Rapidly evaluate your molecule’s pharmaceutical and safety properties with our in vivo drug metabolism and pharmacokinetic (DMPK) services to select the most robust drug formulations.

Learn More

Efficacy Testing

Explore how the novel HuGEMM™ and HuCELL™ platforms can assess the efficacy of your molecule and accelerate your immuno-oncology drug discovery programs.

Learn More

Laboratory Services

Employ cutting-edge multi-omics methods to obtain accurate and comprehensive data for optimal data-based decisions.

Learn More

Pharmacology & Bioanalytical Services

Leverage our suite of structural biology services including, recombinant protein expression and protein crystallography, and target validation services including RNAi.

Learn More

Screens

Find the most appropriate screen to accelerate your drug development: discover in vivo screens with MuScreen™ and in vitro cell line screening with OmniScreen™.

Learn More

Toxicology

Carry out safety pharmacology studies as standalone assessments or embedded within our overall toxicological profiling to assess cardiovascular, metabolic and renal/urinary systems.

Learn More

Preclinical Consulting Services

Learn more about how our consulting services can help to support your journey to the clinic.

Learn More

Our Company

Global CRO in California, USA offering preclinical and translational oncology platforms with high-quality in vivo, in vitro, and ex vivo models.

Learn More

Our Purpose

Learn more about the impact we make through our scientific talent, high-quality standards, and innovation.

Learn More

Our Responsibility

We build a sustainable future by supporting employee growth, fostering leadership, and exceeding customer needs. Our values focus on innovation, social responsibility, and community well-being.

Learn More

Meet Our Leadership Team

We build a sustainable future by fostering leadership, employee growth, and exceeding customer needs with innovation and social responsibility.

Learn More

Scientific Advisory Board

Our Scientific Advisory Board of experts shapes our strategy and ensures top scientific standards in research and development.

Learn More

News & Events

Stay updated with Crown Bioscience's latest news, achievements, and announcements. Check our schedule for upcoming events and plan your visit.

Learn More

Career Opportunities

Join us for a fast-paced career addressing life science needs with innovative technologies. Thrive in a respectful, growth-focused environment.

Learn More

Scientific Publications

Access our latest scientific research and peer-reviewed articles. Discover cutting-edge findings and insights driving innovation and excellence in bioscience.

Learn More

Resources

Discover valuable insights and curated materials to support your R&D efforts. Explore the latest trends, innovations, and expertly curated content in bioscience.

Learn More

Blogs

Explore our blogs for the latest insights, research breakthroughs, and industry trends. Stay educated with expert perspectives and in-depth articles driving innovation in bioscience.

Learn More

  • Platforms
  • Target Solutions
  • Technologies
  • Service Types

Choosing the Right RNA Analysis Methods: Genome-wide RNA-Seq vs. NanoString nCounter® vs. Targeted RNA-Seq Panels

Choosing the Right RNA Analysis Methods: Genome-wide RNA-Seq vs. NanoString nCounter® vs. Targeted RNA-Seq Panels
5:11

In the world of RNA analysis, researchers have an array of technologies at their disposal. Each method comes with its unique strengths, making the choice dependent on specific research needs and constraints. In this post, we'll delve into three popular RNA analysis methods— transcriptome-wide RNA-Seq, NanoString nCounter®, and targeted RNA-Seq panels—comparing their features and discussing when to use each.

Transcriptome-wide RNA-Seq: The Comprehensive Approach

What It Is: Transcriptome -wide RNA sequencing (RNA-Seq) offers a comprehensive view of the transcriptome. By sequencing the entire RNA content of a sample, this method can detect both known and novel transcripts, including splice variants, fusion genes, and non-coding RNAs.

Advantages

  • Broad Coverage: Captures a wide range of transcripts, providing a complete picture of gene expression.
  • High Sensitivity: Detects low-abundance transcripts and novel RNA species.
  • Versatility: Suitable for various applications, from differential gene expression analysis to transcriptome assembly.

Limitations

  • Cost: Higher sequencing depth and data analysis requirements can make it expensive.
  • Complexity: Requires extensive bioinformatics support for data processing and interpretation.

When to Use

  • Discovery Phase: Ideal for exploratory studies where the goal is to identify novel transcripts or understand the full complexity of the transcriptome.
  • Comprehensive Profiling: Useful when a broad overview of gene expression changes is needed, such as in cancer research or developmental biology.

NanoString nCounter: The Simplicity and Precision Approach

What It Is: The NanoString nCounter platform uses digital molecular barcodes to directly count mRNA molecules. This method does not require amplification or reverse transcription, reducing potential biases and preserving sample integrity.

Advantages

  • Direct Quantification: Provides accurate and reproducible measurements of RNA abundance without the need for amplification.
  • Ease of Use: Simple workflow with minimal sample preparation and hands-on time.
  • High Precision: Ideal for validating gene expression changes identified in other studies.

Limitations

  • Limited Multiplexing: Can only measure up to a few hundred genes simultaneously, which may be a constraint for comprehensive studies.
  • Predefined Panels: Restricted to predefined or custom panels, limiting the flexibility to explore unexpected findings.

When to Use

  • Validation and Verification: Excellent for validating RNA-Seq or microarray results due to its precision and reproducibility.
  • Focused Studies: Suitable for studies targeting a specific set of genes, such as biomarker validation or pathway analysis.

Targeted RNA-Seq Panels: The Targeted Approach

What It Is: Targeted RNA-Seq panels focus on sequencing a predefined set of genes or transcripts of interest. This approach leverages the power of next-generation sequencing while concentrating on specific targets, allowing for deep coverage and accurate quantification.

Advantages

  • High Sensitivity and Specificity: Provides detailed information on a specific set of genes with high depth of coverage.
  • Cost-Effective: Lower sequencing cost compared to whole-transcriptome RNA-Seq due to the targeted nature.
  • Scalable: Can be customized to include genes of interest relevant to the study.

Limitations

  • Limited Scope: Only provides data on the selected genes, missing out on broader transcriptomic changes.
  • Panel Design: Requires careful design and validation of the targeted panel.

When to Use

  • Focused Research Questions: Ideal for studies with a predefined focus, such as examining a particular pathway or validating biomarkers.
  • Clinical and Translational Research: Useful in clinical settings where targeted information is needed for diagnosis or treatment decisions.

Comparison Table

Feature Transcriptome-wide
RNA-Seq
NanoString nCounter Targeted
RNA-Seq Panels
Coverage Broad, entire
transcriptome
Limited to selected genes Focused on
predefined genes
Sensitivity High Moderate
to High
High
Cost High Moderate Moderate
to Low
Ease of Use Complex Simple Moderate
Data Analysis Requires extensive
bioinformatics
Minimal bioinformatics
required
Requires moderate
bioinformatics
Multiplexing
Capacity
High Limited
(few hundred genes)
High
(depends on panel design)
Ideal For Exploratory studies,
novel transcript discovery
Validation, precise
quantification
Focused studies,
clinical research
Sample Requirements High Low Moderate
Flexibility High Limited to
predefined panels
High,
customizable panels

Making the Right Choice

When deciding between genome-wide RNA-Seq, NanoString nCounter, and targeted RNA-Seq panels, consider the following factors:

Research Goals Budget Data Complexity Sample Size and
Availability
Are you in the discovery
phase, validating findings,
or focusing on
specific genes?
What are the financial
constraints of your project?
Do you have the
bioinformatics resources
to handle large datasets,
or do you prefer a more
straightforward approach?
How much sample
material do you
have, and what is
its quality?


In Conclusion

Use transcriptome-wide
RNA-Seq
Opt for NanoString
nCounter
Choose targeted
RNA-Seq panels
For comprehensive,
exploratory studies where
capturing the full
transcriptome is crucial.
When precision and
simplicity are needed,
especially for validating
results and focused
gene expression analysis.
For in-depth analysis
of specific genes or
pathways, balancing cost
and data depth.


By carefully considering these factors, you can select the most appropriate RNA analysis method to meet your research needs, ensuring accurate and insightful results. Need some help? Our scientific team is here to help.

Mouse-IO-RNA-Seq-Panel

Mouse I/O RNA-Seq Panel

NGS-based murine targeted 1080-gene panel for I/O and TME studies

banner-nanostring

NanoString nCounter

Unleash the Power of Multiplex Expression Analysis

Genomics-Services

Genomics and Transcriptomics Services

Comprehensive solutions delivering high-quality genomics results and advanced data analysis


Related Posts